- Home
- TNGX vs MIR Comparison
TNGX vs MIR Comparison
Compare TNGX & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- MIR
- Stock Information
- Founded
- TNGX 2014
- MIR 2005
- Country
- TNGX United States
- MIR United States
- Employees
- TNGX N/A
- MIR N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- MIR Industrial Machinery/Components
- Sector
- TNGX Health Care
- MIR Technology
- Exchange
- TNGX Nasdaq
- MIR Nasdaq
- Market Cap
- TNGX 735.0M
- MIR 2.9B
- IPO Year
- TNGX N/A
- MIR N/A
- Fundamental
- Price
- TNGX $6.64
- MIR $14.04
- Analyst Decision
- TNGX Strong Buy
- MIR Strong Buy
- Analyst Count
- TNGX 8
- MIR 2
- Target Price
- TNGX $15.14
- MIR $14.00
- AVG Volume (30 Days)
- TNGX 885.7K
- MIR 2.6M
- Earning Date
- TNGX 11-06-2024
- MIR 10-29-2024
- Dividend Yield
- TNGX N/A
- MIR N/A
- EPS Growth
- TNGX N/A
- MIR N/A
- EPS
- TNGX N/A
- MIR N/A
- Revenue
- TNGX $42,509,000.00
- MIR $821,300,000.00
- Revenue This Year
- TNGX $18.15
- MIR $7.10
- Revenue Next Year
- TNGX N/A
- MIR $5.63
- P/E Ratio
- TNGX N/A
- MIR N/A
- Revenue Growth
- TNGX 26.16
- MIR 8.34
- 52 Week Low
- TNGX $6.33
- MIR $6.70
- 52 Week High
- TNGX $13.01
- MIR $14.80
- Technical
- Relative Strength Index (RSI)
- TNGX 37.15
- MIR 71.80
- Support Level
- TNGX $6.83
- MIR $10.92
- Resistance Level
- TNGX $7.47
- MIR $14.71
- Average True Range (ATR)
- TNGX 0.37
- MIR 0.58
- MACD
- TNGX 0.11
- MIR 0.17
- Stochastic Oscillator
- TNGX 27.31
- MIR 80.91
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allows customers to safely leverage the power of ionizing radiation for the greater good of humanity through critical applications in the medical, nuclear, defense markets, as well as laboratories, scientific research, analysis and exploration. The Company manages its operations through two segments: Medical and Technologies. The Medical segment provides radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers. The Technologies segment is based around the nuclear energy, defense, laboratories, and scientific research markets as well as other industrial markets. It derives maximum revenue from Technologies Segment.